Tatiana Yanova

Tatiana Yanova

Auto-generated profile, based on publicly available information

Tatiana Yanova

Loginov Moscow Clinical Scientific Center

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ИМирина Медакина
ирина Медакина
LTLarisa Tsapkova
Larisa Tsapkova
ВПВера Полякова
Вера Полякова
SNSergey Nikolaev
Sergey Nikolaev
TYTatyana Yanova
Tatyana Yanova
NBNatalia Bodunova
Natalia Bodunova
Helicobacter pylori is one of the most common cause of human infections. Infected patients develop chronic active gastritis in all cases, which can lead to peptic ulcer, atrophic gastritis, gastric cancer and gastric MALT-lymphoma. The prevalence of H. pylori infection in the population has regional characteristics and can reach 80%. Constantly increasing antibiotic resistance of H. pylori is a major cause of treatment failure and a major problem. According to the VI Maastricht Consensus, two main strategies for choosing eradication therapy are recommended: individualized based on evaluating sensitivity to antibacterial drugs (phenotypic or molecular genetic method) prior to their appointment, and empirical, which takes into account data on local H. pylori resistance to clarithromycin and monitoring effectiveness schemes in the region. Therefore, the determination of H. pylori resistance to antibiotics, especially clarithromycin, prior to choosing therapeutic strategy is extremely important for the implementation of these treatment regimens.

25 January 2023 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
ВПВера Полякова
Вера Полякова
NBNatalia Bodunova
Natalia Bodunova
KRKonstantin A. Rumyantsev
Konstantin A. Rumyantsev
IKIgor Khatkov
Igor Khatkov
Dmitry S BordinDmitry S Bordin
Dmitry S Bordin
TYTatiana Yanova
Tatiana Yanova

12 June 2022 in Koloproktologia
Verified
Journal Article
Open access
PDF file
TYT. I. Yanova
T. I. Yanova
NBNatalia Bodunova
Natalia Bodunova
IKI. E. Khatkov
I. E. Khatkov
ATAleksey Tsukanov
Aleksey Tsukanov
NKN. G. Khodos
N. G. Khodos
ВПВера Полякова
Вера Полякова
   Introduction: Peutz-Jeghers syndrome (PEUTZ-JEGHERS SYNDROME; PJS; OMIM#175200) is hereditary tumor syndrome and is characterized by the occurrence of hamartomatous polyps of gastrointestinal tract, melanocytic pigmentation of the skin and mucous membranes, as well as a high predisposition to malignant tumors of various locations. Despite the fact that the clinical features of PJS are currently well understood, the nature of the variability in the phenotypic manifestations of the disease has not been fully described.   Aims: to determine the phenotypic and clinical features in patients with PJS depending on the type of mutation in the STK11 gene.   Patients and methods: the clinical and genetic data of 3 patients aged 21, 28 and 39 years with clinical signs of PJS are presented. All patients underwent medical genetic counseling and molecular genetic diagnostics of the STK11 gene using NGS and MLPA methods.   Results: large deletions of ex2-8 and ex1 in the STK11 gene were revealed in two patients, and one patient showed a splice site variant c.921-1G > A. The identified variant ex2-8 has not previously been described in international databases. When evaluating the clinical and genetic features, the most severe picture of the disease was in a patient with an extended deletion of exons 2-8, large number of polyps and surgical procedures in history. However, in this case, melanocytic pigmentation became less with age, in contrast to patients with a splice site mutation and a single exon deletion. No cancers were detected in the patients.   Conclusion: the molecular genetic test made it possible to confirm the clinical diagnosis of PJS, based on various phenotypic features, and to work out the personalized plan for follow-up. Evaluation of the genotype-phenotype correlations will be possible with the development of a unified register of mutation carriers.

19 April 2023 in Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
Verified
Journal Article
Open access
PDF file
LFL. D. Firsova
L. D. Firsova
VOV. V. Ogarev
V. V. Ogarev
AKAydana Kanatbek Kyzy
Aydana Kanatbek Kyzy
NRN. V. Romashkina
N. V. Romashkina
TYT. I. Yanova
T. I. Yanova
NBNatalia Bodunova
Natalia Bodunova
Relevance. Informing patients about the carriage of a pathogenic mutation may result in a psychologically traumatizing situation, characterized by acute stress reactions, post-traumatic stress disorder symptoms, or anxiety-depressive disorder. This highlights the importance of psychological counseling.Objective. To investigate the effectiveness of psychological support in a patient with mutations in genes associated with hereditary breast cancer.Materials and methods. Description of patient's medical history and results of instrumental psychological diagnosis after identifying a pathogenic mutation in the CHEK2 gene, which increases a risk of developing breast cancer to 20–40 % via genetic testing.Results. The nature of emotional response in this case is determined by personal history — identification of ideas about one's possible disease with mother's one. The conducted psychological consultations mitigated acute stress reactions and minimized the perception of received genetic information as a psychologically traumatic event. Furthermore, significant positive shifts were observed in the formation of adaptive stresscoping strategies, awareness of one's own mental resources, and reinforcement of adherence to the dynamic observation plan.Conclusion: Patients in situations involving the identification of mutations in genes associated with hereditary breast cancer require a personalized approach. Development of criteria for psychological support should be aimed at improving patients' quality of life not only in the immediate aftermath of information disclosure but also in the long term.

22 October 2024 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
TYT. I. Yanova
T. I. Yanova
EKElena Kondatyeva
Elena Kondatyeva
Hereditary pancreatitis is a genetically determined disease that occurs in 1-10% of adult patients with chronic pancreatitis and in more than 50% of pediatric patients. Patients with hereditary pancreatitis have an increased risk of developing complications, pancreatic cancer, therefore early detection is important for screening for the occurrence of malignant neoplasm. The purpose of the review was to analyze the literature data on modern approaches to the diagnosis of hereditary pancreatitis and to familiarize with diagnostic methods. Methods A literature search was conducted in the databases PubMed, Web of Science, UpToDate, genetic databases using keywords. The data of 80 articles and the expert opinion of specialists providing care to patients with pancreatitis were used. Conclusion Carrying out molecular genetic diagnostics plays an important role in the study of pathogenesis, assessment of variants of the course of the disease. The article presents the currently known aspects that are important for working with patients with hereditary pancreatitis.

25 January 2023 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
NFNina Fadeeva
Nina Fadeeva
IKIgor Khatkov
Igor Khatkov
NBNatalia Bodunova
Natalia Bodunova
OKOleg Knyazev
Oleg Knyazev
DBDmitry Bordin
Dmitry Bordin
TYTatiana Yanova
Tatiana Yanova